\frametitle{Quality of drug articles: NEJM}
- \includegraphics[width=0.45\textwidth]{figures/Pradaxa_tweet_FDAMedWach.png}
+ \includegraphics[width=0.49\textwidth]{figures/Pradaxa_tweet_FDAMedWach.png}
% from https://twitter.com/FDAMedWatch/status/281547908095041536
% = first one in the list at http://www.nejm.org/doi/suppl/10.1056/NEJMp1401767/suppl_file/nejmp1401767_appendix.pdf
- $\Longrightarrow$
- \includegraphics[width=0.45\textwidth]{figures/Dabitragan_Contraindications_WP_FDA_warning}
-
+ \includegraphics[width=0.49\textwidth]{figures/Dabitragan_Contraindications_WP_FDA_warning}
+
+ \tikz{\node [yshift=1.5cm,xshift=-0.4cm] at (current page.center) {\includegraphics[width=1.5cm]{figures/long-arrow-right.png}};}
\begin{itemize}
\larger \larger
\item The US Food and Drug Administration (\e{FDA}) frequently